Their results were managed to bring into agreement when they identified multiple preserved Stat3 binding sites upstream of the miR-21 gene promoter and demonstrated that systemic administration of a miR-21-specific antisense oligonucleotide antagomir lowered established gastric tumor volume in the Gp130 F/F mouse model of inflammation-associated gastric cancer. The gene discussed is STAT3; the disease is gastric cancer.